These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8279362)

  • 1. New strategies for enhancing the speed and rate of coronary reperfusion.
    Agnelli G
    Am J Cardiol; 1993 Dec; 72(19):51G-58G. PubMed ID: 8279362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombolytic and antithrombotic treatment in myocardial infarction: main achievements and future perspectives.
    Agnelli G
    Int J Cardiol; 1995 Aug; 49 Suppl():S77-87. PubMed ID: 7591320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New developments in thrombolytic therapy.
    Collen D; Gold HK
    Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Arterial permeability, objective of thrombolytic therapy].
    Bassand JP; Schiele F; Bernard Y; Anguenot T
    Arch Mal Coeur Vaiss; 1992 May; 85(5 Suppl):677-87. PubMed ID: 1530409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombolytic therapy in Europe: current status.
    Vahanian A
    Eur Heart J; 1996 Sep; 17 Suppl E():21-7. PubMed ID: 11824000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is survival in acute myocardial infarction related to thrombolytic efficacy or the open-artery hypothesis? A controversy to be investigated with GUSTO.
    Bates ER
    Chest; 1992 Apr; 101(4 Suppl):140S-150S. PubMed ID: 1555479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction.
    GUSTO Angiographic Investigators
    N Engl J Med; 1993 Nov; 329(22):1615-22. PubMed ID: 8232430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the early open infarct vessel hypothesis.
    Topol EJ
    Am J Cardiol; 1993 Dec; 72(19):40G-45G. PubMed ID: 8279360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombolytic therapy in acute myocardial infarction.
    Woo KS; White HD
    Curr Opin Cardiol; 1994 Jul; 9(4):471-82. PubMed ID: 7919592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefit of early sustained reperfusion in patients with prior myocardial infarction (the GUSTO-I trial). Global Utilization of Streptokinase and TPA for occluded arteries.
    Brieger DB; Mak KH; White HD; Kleiman NS; Miller DP; Vahanian A; Ross AM; Califf RM; Topol EJ
    Am J Cardiol; 1998 Feb; 81(3):282-7. PubMed ID: 9468068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The current controversies regarding reperfusion therapy for acute myocardial infarction.
    Ross AM
    Z Kardiol; 1993; 82 Suppl 2():113-7. PubMed ID: 8328187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of prehospital thrombolytic therapy in ST-segment elevation acute coronary syndrome (<12 hours).
    Goldstein P; Wiel E
    Minerva Anestesiol; 2005 Jun; 71(6):297-302. PubMed ID: 15886591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reperfusion strategies in acute ST-elevation myocardial infarction: an overview of current status.
    De Luca G; Suryapranata H; Marino P
    Prog Cardiovasc Dis; 2008; 50(5):352-82. PubMed ID: 18313480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development of new thrombolytic substances].
    Zeymer U; Neuhaus KL
    Herz; 1994 Dec; 19(6):314-25. PubMed ID: 7843688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reperfusion therapy for acute myocardial infarction. Which strategy for which patient?
    Boersma E; Steyerberg EW; Van der Vlugt MJ; Simoons ML
    Drugs; 1998 Jul; 56(1):31-48. PubMed ID: 9664197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current issues in reperfusion therapy.
    Gersh BJ
    Am J Cardiol; 1998 Oct; 82(8B):3P-11P. PubMed ID: 9809886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary angioplasty versus intravenous thrombolysis for acute myocardial infarction.
    Cucherat M; Bonnefoy E; Tremeau G
    Cochrane Database Syst Rev; 2000; (2):CD001560. PubMed ID: 10796812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New developments in thrombolytic therapy.
    Collen D; Gold HK
    Verh K Acad Geneeskd Belg; 1989; 51(3):191-228; discussion 229. PubMed ID: 2686261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New thrombolytic strategies.
    Van de Werf F
    Aust N Z J Med; 1993 Dec; 23(6):763-5. PubMed ID: 8141722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Physiopathologic basis of the use of thrombolytic agents during the acute phase of myocardial infarction].
    Castaigne A; Duval-Moulin AM; Dubois-Randé JL; Merlet P
    Arch Mal Coeur Vaiss; 1989 Oct; 82 Spec No 3():15-20. PubMed ID: 2512883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.